Clinical trial
Dopaminergic Enhancement of Learning and Memory in Aphasia
NCT00102869 · University Hospital Muenster, Other · Completed
Key facts
| NCT number | NCT00102869 |
|---|---|
| Title | Dopaminergic Enhancement of Learning and Memory in Aphasia |
| Official title | Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Aphasia) |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | German Federal Ministry of Education and Research |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident, Aphasia |
| Intervention type | Drug |
| Interventions | levodopa |
| Enrollment | 12 |
| Start date | Jan 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Feb 4, 2005 |
| Last update posted | Oct 7, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: